Location History:
- Heverlee, BE (2018 - 2021)
- Leuven, BE (2021 - 2024)
Company Filing History:
23 out of 346 
20 out of 159 
4 out of 34 
Years Active: 2018-2025
Title: Dorothée Alice Marie-Eve Bardiot: A Prolific Inventor in the Field of Anti-viral Compounds
Introduction:
In the ever-evolving world of pharmaceuticals, inventors play a crucial role in developing novel compounds to combat various diseases and conditions. One such exceptional inventor is Dorothée Alice Marie-Eve Bardiot, hailing from Heverlee, Belgium. With an impressive portfolio of patents, Bardiot has made significant contributions in the field of anti-viral compounds, particularly in preventing and treating dengue viral infections. In this article, we will delve into Bardiot's latest patents, career highlights, notable collaborations, and recognize her invaluable contributions to the field.
Latest Patents:
Bardiot's recent patents have focused on the development of anti-viral compounds, with an emphasis on combating dengue viral infections. One of her notable inventions includes compounds of Formula (I), or their pharmaceutically acceptable salts, which have shown promising results in treating various diseases and conditions. These compounds have the potential to revolutionize the field of antiviral therapeutics.
Additionally, Bardiot has contributed significantly to the prevention and treatment of dengue viral infections. Her mono- or di-substituted indole derivatives have displayed remarkable inhibitory effects on dengue viral replication. These compounds, used either individually or in combination, have demonstrated efficacy as potential medicines against dengue viral infections. Bardiot's inventions in this area open up new avenues for the prevention and treatment of this widespread viral disease.
Career Highlights:
During her illustrious career, Bardiot has collaborated with prestigious institutions and pharmaceutical companies, further enhancing her expertise in the field of anti-viral compounds. Bardiot has worked with the renowned Katholieke Universiteit Leuven and the esteemed Janssen Pharmaceutica Nv. Her affiliation with these esteemed organizations has allowed her to conduct groundbreaking research and translate her innovative ideas into tangible inventions.
Collaborations:
Bardiot's success is not only a testament to her individual brilliance but also to her collaborative nature. Throughout her career, she has worked alongside talented professionals, including colleagues like Pierre Jean-Marie Bernard Raboisson and Bart Rudolf Romanie Kesteleyn. These collaborations have fuelled the exchange of ideas and expertise, leading to the development of groundbreaking inventions. Bardiot's ability to collaborate effectively highlights her commitment to advancing the field and finding solutions to challenging viral infections.
Conclusion:
Dorothée Alice Marie-Eve Bardiot's significant contributions in the field of anti-viral compounds, particularly in the prevention and treatment of dengue viral infections, have marked her as a pioneering inventor. With a remarkable portfolio of patents, her inventions have the potential to revolutionize antiviral therapeutics. Bardiot's career highlights and collaborations exemplify her dedication to pushing the boundaries of scientific innovation. Her work not only enhances our understanding of viral infections but also provides hope for the development of effective treatments in the future.